Trial Profile
Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2009
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary) ; Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms GLANCE
- Sponsors Biogen Idec